110 related articles for article (PubMed ID: 11291553)
21. Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary.
el-Roeiy A; Chen X; Roberts VJ; LeRoith D; Roberts CT; Yen SS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1411-8. PubMed ID: 8077342
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers.
Michell NP; Langman MJ; Eggo MC
Br J Cancer; 1997; 76(1):60-6. PubMed ID: 9218734
[TBL] [Abstract][Full Text] [Related]
24. Expression of mRNAs encoding insulin-like growth factor (IGF) ligands, IGF receptors and IGF binding proteins during follicular growth and atresia in the ovine ovary throughout the oestrous cycle.
Hastie PM; Haresign W
Anim Reprod Sci; 2006 May; 92(3-4):284-99. PubMed ID: 16023803
[TBL] [Abstract][Full Text] [Related]
25. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium.
Tennant MK; Thrasher JB; Twomey PA; Drivdahl RH; Birnbaum RS; Plymate SR
J Clin Endocrinol Metab; 1996 Oct; 81(10):3774-82. PubMed ID: 8855837
[TBL] [Abstract][Full Text] [Related]
26. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
27. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
[TBL] [Abstract][Full Text] [Related]
28. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract][Full Text] [Related]
29. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.
Silha JV; Sheppard PC; Mishra S; Gui Y; Schwartz J; Dodd JG; Murphy LJ
Endocrinology; 2006 May; 147(5):2112-21. PubMed ID: 16469805
[TBL] [Abstract][Full Text] [Related]
31. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.
Fixemer T; Wissenbach U; Flockerzi V; Bonkhoff H
Oncogene; 2003 Oct; 22(49):7858-61. PubMed ID: 14586412
[TBL] [Abstract][Full Text] [Related]
32. Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors.
Bondy CA; Zhou J; Chin E; Reinhardt RR; Ding L; Roth RA
J Clin Invest; 1994 Mar; 93(3):966-73. PubMed ID: 8132782
[TBL] [Abstract][Full Text] [Related]
33. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
Pekonen F; Partanen S; Mäkinen T; Rutanen EM
Cancer Res; 1988 Mar; 48(5):1343-7. PubMed ID: 2963690
[TBL] [Abstract][Full Text] [Related]
34. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
35. Relative expression and localization of the insulin-like growth factor system components in the fetal, child and adult intestine.
Freier S; Eran M; Reinus C; Ariel I; Faber J; Wilschanski M; Braverman D
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):202-9. PubMed ID: 15699698
[TBL] [Abstract][Full Text] [Related]
36. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
37. Expression of insulin-like growth factors and their receptors in human meningiomas.
Lichtor T; Kurpakus MA; Gurney ME
J Neurooncol; 1993 Sep; 17(3):183-90. PubMed ID: 8164055
[TBL] [Abstract][Full Text] [Related]
38. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
39. Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells.
Xu ZD; Oey L; Mohan S; Kawachi MH; Lee NS; Rossi JJ; Fujita-Yamaguchi Y
Endocrinology; 1999 May; 140(5):2134-44. PubMed ID: 10218964
[TBL] [Abstract][Full Text] [Related]
40. Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting.
Bailyes EM; Navé BT; Soos MA; Orr SR; Hayward AC; Siddle K
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):209-15. PubMed ID: 9355755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
